| Dr Susan E Abel, MD | |
|
591 W Hollis St, Nashua, NH 03062-1323 | |
| (603) 577-4400 | |
| (693) 577-4454 |
| Full Name | Dr Susan E Abel |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 591 W Hollis St, Nashua, New Hampshire |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093826893 | NPI | - | NPPES |
| 30209341 | Medicaid | NH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2080P0204X | Pediatrics - Pediatric Emergency Medicine | 25MA08085800 (New Jersey) | Secondary |
| 208000000X | Pediatrics | 14484 (New Hampshire) | Primary |
| Entity Name | Dartmouth-hitchcock Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386697803 PECOS PAC ID: 4183537509 Enrollment ID: O20031111000313 |
News Archive
A "year-long assessment done by the Canadian Academy of Health Sciences concluded there is a strong rationale for Canada to play a more strategic role in global health, while recognizing the scale of humanitarian needs," and to "focus on five areas where its research is strongest, including indigenous health," the Globe and Mail reports.
In a clinical study, women with an aggressive form of breast cancer experienced a median survival of 14 months when treated with an investigational combination of TYKERB® (lapatinib) plus HERCEPTIN® (trastuzumab). The results of the Phase III study in HER2-positive metastatic breast cancer were presented during the 32nd Annual CTRC-AACR San Antonio Breast Cancer Symposium, held in San Antonio, Texas (Dec. 9 - 13).
A team led by Vanderbilt University investigators has discovered two new genes - both coding for the signaling protein calmodulin - associated with severe early-onset disorders of heart rhythm.
According to researchers women who have their babies very close together, along with women who never have children, are at risk of an earlier death and poorer health in later life.
› Verified 5 days ago
| Entity Name | Mary Hitchcock Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023092053 PECOS PAC ID: 4486561164 Enrollment ID: O20031126000258 |
News Archive
A "year-long assessment done by the Canadian Academy of Health Sciences concluded there is a strong rationale for Canada to play a more strategic role in global health, while recognizing the scale of humanitarian needs," and to "focus on five areas where its research is strongest, including indigenous health," the Globe and Mail reports.
In a clinical study, women with an aggressive form of breast cancer experienced a median survival of 14 months when treated with an investigational combination of TYKERB® (lapatinib) plus HERCEPTIN® (trastuzumab). The results of the Phase III study in HER2-positive metastatic breast cancer were presented during the 32nd Annual CTRC-AACR San Antonio Breast Cancer Symposium, held in San Antonio, Texas (Dec. 9 - 13).
A team led by Vanderbilt University investigators has discovered two new genes - both coding for the signaling protein calmodulin - associated with severe early-onset disorders of heart rhythm.
According to researchers women who have their babies very close together, along with women who never have children, are at risk of an earlier death and poorer health in later life.
› Verified 5 days ago
| Entity Name | Dartmouth-hitchcock Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548210198 PECOS PAC ID: 4183537509 Enrollment ID: O20040809000442 |
News Archive
A "year-long assessment done by the Canadian Academy of Health Sciences concluded there is a strong rationale for Canada to play a more strategic role in global health, while recognizing the scale of humanitarian needs," and to "focus on five areas where its research is strongest, including indigenous health," the Globe and Mail reports.
In a clinical study, women with an aggressive form of breast cancer experienced a median survival of 14 months when treated with an investigational combination of TYKERB® (lapatinib) plus HERCEPTIN® (trastuzumab). The results of the Phase III study in HER2-positive metastatic breast cancer were presented during the 32nd Annual CTRC-AACR San Antonio Breast Cancer Symposium, held in San Antonio, Texas (Dec. 9 - 13).
A team led by Vanderbilt University investigators has discovered two new genes - both coding for the signaling protein calmodulin - associated with severe early-onset disorders of heart rhythm.
According to researchers women who have their babies very close together, along with women who never have children, are at risk of an earlier death and poorer health in later life.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Susan E Abel, MD 591 W Hollis St, Nashua, NH 03062-1323 Ph: (603) 577-4400 | Dr Susan E Abel, MD 591 W Hollis St, Nashua, NH 03062-1323 Ph: (603) 577-4400 |
News Archive
A "year-long assessment done by the Canadian Academy of Health Sciences concluded there is a strong rationale for Canada to play a more strategic role in global health, while recognizing the scale of humanitarian needs," and to "focus on five areas where its research is strongest, including indigenous health," the Globe and Mail reports.
In a clinical study, women with an aggressive form of breast cancer experienced a median survival of 14 months when treated with an investigational combination of TYKERB® (lapatinib) plus HERCEPTIN® (trastuzumab). The results of the Phase III study in HER2-positive metastatic breast cancer were presented during the 32nd Annual CTRC-AACR San Antonio Breast Cancer Symposium, held in San Antonio, Texas (Dec. 9 - 13).
A team led by Vanderbilt University investigators has discovered two new genes - both coding for the signaling protein calmodulin - associated with severe early-onset disorders of heart rhythm.
According to researchers women who have their babies very close together, along with women who never have children, are at risk of an earlier death and poorer health in later life.
› Verified 5 days ago
Patricia Lee Sargent, DO Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 280 Main St, Suite 410, Nashua, NH 03060 Phone: 603-595-7388 Fax: 603-595-8624 | |
John Thompson, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 8 Prospect St, Nashua, NH 03060 Phone: 603-577-2565 | |
Dr. Jennifer Page, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 155 Kinsley St, Nashua, NH 03060 Phone: 603-889-6671 | |
Dr. Ranjan N Dandekar, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 280 Main St Ste 410, Nashua, NH 03060 Phone: 603-595-7388 | |
Anjana Neupaney, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 22 Prospect St, Nashua, NH 03060 Phone: 603-883-1626 Fax: 603-881-9914 | |
Dr. Cara Douville Kaupp, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 383 E Dunstable Rd, Nashua, NH 03062 Phone: 603-891-0083 Fax: 603-891-0847 | |
Dr. Valerie Atkins, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 8 Prospect St, Nashua, NH 03060 Phone: 603-577-2616 Fax: 603-577-2084 |